Clinical Trials Browser

Vaccine-Preventable Diseases, COVID-19, Vaccination Hesitancy, Influenza, Human, Patient Acceptance of Health Care, Colorectal Neoplasms, Health Behavior

NCT02860039 2024-10-22

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

Phase 2 Completed

170 enrolled 11 charts

Influenza, Human, Neoplasms

NCT00965354 2024-09-19

MOSAIC

Completed

131 enrolled 4 charts

Lymphoid

Influenza, Human, Lymphoma, Follicular

NCT02566265 2019-01-30

SHIVERING 2

Phase 2 Completed

122 enrolled 10 charts

LymphoidPlasma cell

Influenza, Human, Waldenstrom Macroglobulinemia, Multiple Myeloma

NCT01215981 2017-12-28

Influenza Vaccine Post Allogeneic Transplant

Phase NA Terminated

68 enrolled 6 charts

Other hematologic neoplasm

Influenza, Human, Hematologic Neoplasms

NCT00112112 2017-08-14

Safety Study to Evaluate FluMist in Immunocompromised Children

Phase 1 Completed

20 enrolled 70 charts

Influenza, Human, Neoplasms

NCT01205581 2016-09-23

Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV

Phase 2 Completed

85 enrolled 24 charts

Influenza, Human, Neoplasms

NCT01666782 2016-06-24

IMMUNE

Phase 2 Completed

105 enrolled 10 charts

Influenza, Human, Neoplasms

Clinical Trials

BENEFIT-C

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

MOSAIC

SHIVERING 2

Influenza Vaccine Post Allogeneic Transplant

Safety Study to Evaluate FluMist in Immunocompromised Children

Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV

IMMUNE